Skip to main content
HR 7722 116th Congress House

Matt’s Act

Official title: To limit the price of insulin drugs accessible for participants, beneficiaries, and enrollees enrolled in group or individual health insurance coverage and gro… Show full official titleShow less

Official title: To limit the price of insulin drugs accessible for participants, beneficiaries, and enrollees enrolled in group or individual health insurance coverage and group health plans and for uninsured individuals who have diabetes, and for other purposes.

Introduced: July 22, 2020 See on congress.gov
Health Business recordsCongressional oversightDigestive and metabolic diseasesDrug therapy
More subjectsShow fewer subjects
Health care costs and insuranceHealth care coverage and accessInflation and pricesPrescription drugs
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 22, 2020
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 22, 2020
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action July 22, 2020

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

 Plain-English summary Congressional Research Service

Matt's Act

This bill limits the amount that private health insurance plans may charge plan holders for insulin drugs to a maximum of $20, or $0 for high deductible plans; pharmacies may charge an uninsured individual who has diabetes the average net price of such drugs after deducting any rebates and discounts provided by drug manufacturers, plus limited additional charges for distributing and dispensing costs.

 Related & companion bills 1
  • HR 4813 Reintroduced Bill Matt’s Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 1
All 1 Democratic 1
D
Craig, Angie
Minnesota · Jul 22, 2020
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 7722: Matt’s Act. 116th Congress. Open America. https://openamerica.io/bill/116-HR-7722/
MLA
"H.R. 7722: Matt’s Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-7722/.
Bluebook (legal)
H.R. 7722, 116th Cong. (2026), https://openamerica.io/bill/116-HR-7722/.
Markdown link
[H.R. 7722: Matt’s Act](https://openamerica.io/bill/116-HR-7722/)
Report a problem